IV trivalent saccharose hydroxide ferrous + Oral ferrous fumarate + Oral and intravenous Placebo
ApprovedCompleted 0 watching 0 views this week📈 Rising
77
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Anaemia
Conditions
Anaemia
Trial Timeline
May 1, 2007 → May 1, 2009
NCT ID
NCT01078818About IV trivalent saccharose hydroxide ferrous + Oral ferrous fumarate + Oral and intravenous Placebo
IV trivalent saccharose hydroxide ferrous + Oral ferrous fumarate + Oral and intravenous Placebo is a approved stage product being developed by Rafael Holdings for Anaemia. The current trial status is completed. This product is registered under clinical trial identifier NCT01078818. Target conditions include Anaemia.
Hype Score Breakdown
Clinical
30
Activity
20
Company
2
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01078818 | Approved | Completed |
Competing Products
11 competing products in Anaemia
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| DS-1093 + placebo | Daiichi Sankyo | Phase 1 | 33 |
| Hetrombopag Olamine Tablet | Jiangsu Hengrui Medicine | Phase 1 | 33 |
| Hetrombopag Olamine Tablet；Ciclosporin Soft Capsule | Jiangsu Hengrui Medicine | Phase 1 | 33 |
| Hetrombopag Olamine Tablet | Jiangsu Hengrui Medicine | Phase 1 | 33 |
| Neorecormon | Roche | Approved | 85 |
| SAR445088 | Sanofi | Phase 1 | 32 |
| BIVV020 | Sanofi | Phase 1 | 32 |
| G-CSF + Early retreatment with ATG | Sanofi | Phase 3 | 76 |
| rilzabrutinib + placebo | Sanofi | Phase 3 | 76 |
| Ferrum Lek® (iron (III) hydroxide polymaltosate), 100 mg chewable tablets (Lek d.d., Slovenia) + MALTOFER® (iron (III) hydroxide polymaltosate), 100 mg chewable tablets (Vifor S.A., Switzerland) | Sandoz Group | Phase 3 | 74 |
| Ferric Maltol | Medpace | Phase 1 | 30 |
Other Products from Rafael Holdings
Varenicline + Nicotine patchApproved
77
Polyethylene glycol 4000 + Macrogol 3350 plus ascorbic acidApproved
77
inhaled corticosteroid plus LABA plus oral corticosteroidApproved
77
Insulin + insulinApproved
77
Tacrolimus with rapid steroid withdrawal + Tacrolimus with steroids minimization + CsA with steroid minimizationApproved
77